196 related articles for article (PubMed ID: 27622541)
1. Development and evaluation of a removable tissue-engineered muscle with artificial tendons.
Nakamura T; Takagi S; Kamon T; Yamasaki KI; Fujisato T
J Biosci Bioeng; 2017 Feb; 123(2):265-271. PubMed ID: 27622541
[TBL] [Abstract][Full Text] [Related]
2. Enhanced contractile force generation by artificial skeletal muscle tissues using IGF-I gene-engineered myoblast cells.
Sato M; Ito A; Kawabe Y; Nagamori E; Kamihira M
J Biosci Bioeng; 2011 Sep; 112(3):273-8. PubMed ID: 21646045
[TBL] [Abstract][Full Text] [Related]
3. Fabrication of scaffold-free contractile skeletal muscle tissue using magnetite-incorporated myogenic C2C12 cells.
Fujita H; Shimizu K; Yamamoto Y; Ito A; Kamihira M; Nagamori E
J Tissue Eng Regen Med; 2010 Aug; 4(6):437-43. PubMed ID: 20084621
[TBL] [Abstract][Full Text] [Related]
4. Effect of cell-extracellular matrix interaction on myogenic characteristics and artificial skeletal muscle tissue.
Ding R; Horie M; Nagasaka S; Ohsumi S; Shimizu K; Honda H; Nagamori E; Fujita H; Kawamoto T
J Biosci Bioeng; 2020 Jul; 130(1):98-105. PubMed ID: 32278672
[TBL] [Abstract][Full Text] [Related]
5. Preparation of artificial skeletal muscle tissues by a magnetic force-based tissue engineering technique.
Yamamoto Y; Ito A; Kato M; Kawabe Y; Shimizu K; Fujita H; Nagamori E; Kamihira M
J Biosci Bioeng; 2009 Dec; 108(6):538-43. PubMed ID: 19914590
[TBL] [Abstract][Full Text] [Related]
6. Optimizing the structure and contractility of engineered skeletal muscle thin films.
Sun Y; Duffy R; Lee A; Feinberg AW
Acta Biomater; 2013 Aug; 9(8):7885-94. PubMed ID: 23632372
[TBL] [Abstract][Full Text] [Related]
7. Cell Density and Joint microRNA-133a and microRNA-696 Inhibition Enhance Differentiation and Contractile Function of Engineered Human Skeletal Muscle Tissues.
Cheng CS; Ran L; Bursac N; Kraus WE; Truskey GA
Tissue Eng Part A; 2016 Apr; 22(7-8):573-83. PubMed ID: 26891613
[TBL] [Abstract][Full Text] [Related]
8. Cyclic mechanical preconditioning improves engineered muscle contraction.
Moon du G; Christ G; Stitzel JD; Atala A; Yoo JJ
Tissue Eng Part A; 2008 Apr; 14(4):473-82. PubMed ID: 18399787
[TBL] [Abstract][Full Text] [Related]
9. Effects of type IV collagen on myogenic characteristics of IGF-I gene-engineered myoblasts.
Ito A; Yamamoto M; Ikeda K; Sato M; Kawabe Y; Kamihira M
J Biosci Bioeng; 2015 May; 119(5):596-603. PubMed ID: 25454061
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stem cells and myoblast differentiation under HGF and IGF-1 stimulation for 3D skeletal muscle tissue engineering.
Witt R; Weigand A; Boos AM; Cai A; Dippold D; Boccaccini AR; Schubert DW; Hardt M; Lange C; Arkudas A; Horch RE; Beier JP
BMC Cell Biol; 2017 Feb; 18(1):15. PubMed ID: 28245809
[TBL] [Abstract][Full Text] [Related]
11. Effect of heat stress on contractility of tissue-engineered artificial skeletal muscle.
Takagi S; Nakamura T; Fujisato T
J Artif Organs; 2018 Jun; 21(2):207-214. PubMed ID: 29362934
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional co-culture of C2C12/PC12 cells improves skeletal muscle tissue formation and function.
Ostrovidov S; Ahadian S; Ramon-Azcon J; Hosseini V; Fujie T; Parthiban SP; Shiku H; Matsue T; Kaji H; Ramalingam M; Bae H; Khademhosseini A
J Tissue Eng Regen Med; 2017 Feb; 11(2):582-595. PubMed ID: 25393357
[TBL] [Abstract][Full Text] [Related]
13. Novel method for fabrication of skeletal muscle construct from the C2C12 myoblast cell line using serum-free medium AIM-V.
Fujita H; Shimizu K; Nagamori E
Biotechnol Bioeng; 2009 Aug; 103(5):1034-41. PubMed ID: 19350625
[TBL] [Abstract][Full Text] [Related]
14. In vitro drug testing based on contractile activity of C2C12 cells in an epigenetic drug model.
Ikeda K; Ito A; Imada R; Sato M; Kawabe Y; Kamihira M
Sci Rep; 2017 Mar; 7():44570. PubMed ID: 28300163
[TBL] [Abstract][Full Text] [Related]
15. Synergy between myogenic and non-myogenic cells in a 3D tissue-engineered craniofacial skeletal muscle construct.
Brady MA; Lewis MP; Mudera V
J Tissue Eng Regen Med; 2008 Oct; 2(7):408-17. PubMed ID: 18720445
[TBL] [Abstract][Full Text] [Related]
16. Effects of heat stimulation and l-ascorbic acid 2-phosphate supplementation on myogenic differentiation of artificial skeletal muscle tissue constructs.
Ikeda K; Ito A; Sato M; Kanno S; Kawabe Y; Kamihira M
J Tissue Eng Regen Med; 2017 May; 11(5):1322-1331. PubMed ID: 26033935
[TBL] [Abstract][Full Text] [Related]
17. Rapid formation of functional muscle in vitro using fibrin gels.
Huang YC; Dennis RG; Larkin L; Baar K
J Appl Physiol (1985); 2005 Feb; 98(2):706-13. PubMed ID: 15475606
[TBL] [Abstract][Full Text] [Related]
18. In vivo tendon engineering with skeletal muscle derived cells in a mouse model.
Chen B; Wang B; Zhang WJ; Zhou G; Cao Y; Liu W
Biomaterials; 2012 Sep; 33(26):6086-97. PubMed ID: 22672832
[TBL] [Abstract][Full Text] [Related]
19. Effects of a combined mechanical stimulation protocol: Value for skeletal muscle tissue engineering.
Boonen KJ; Langelaan ML; Polak RB; van der Schaft DW; Baaijens FP; Post MJ
J Biomech; 2010 May; 43(8):1514-21. PubMed ID: 20189177
[TBL] [Abstract][Full Text] [Related]
20. Engineering a 3D in vitro model of human skeletal muscle at the single fiber scale.
Urciuolo A; Serena E; Ghua R; Zatti S; Giomo M; Mattei N; Vetralla M; Selmin G; Luni C; Vitulo N; Valle G; Vitiello L; Elvassore N
PLoS One; 2020; 15(5):e0232081. PubMed ID: 32374763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
